Considering Inflammatory Comorbidities in Patients with HS

The lecture discusses inflammatory comorbidities associated with Hidradenitis Suppurativa (HS) and highlights key considerations for treatment. The speaker reviews a clinical case of a 27-year-old female with HS, pyoderma gangrenosum (PG), and associated spondyloarthritis, emphasizing the prevalence of PG in HS patients. The talk details the use of TNF alpha inhibitors as first-line treatment, along with the potential need to increase dosing based on patient response, emphasizing that many patients, including this case, experience complications that necessitate adjustment of therapy. The speaker notes the importance of understanding the patient's quality of life, using a validated questionnaire to assess the impact of HS on daily living. Practical guidance is also provided for screening additional comorbidities like acne, dissecting cellulitis, and inflammatory bowel disease. The lecture concludes by reinforcing the effectiveness of TNF alpha inhibitors and the need for careful management of HS-related conditions to improve patient outcomes.